Background and Objective Bronchiectasis exacerbations are significant events in the natural
course of the disease and determine long-term clinical outcomes. This review aims to …

In recent years, personalized or precision medicine has made effective inroads into the
management of diseases, including respiratory diseases. The route to implementing this …

The current literature provides a body of evidence on C-Reactive Protein (CRP) and its
potential role in inflammation. However, most pieces of evidence are sparse and …

Due to their potent anti-inflammatory capacity (particularly in predominantly eosinophilic
inflammation) and immunosuppressive properties, inhaled corticosteroids (ICSs) are widely …

Bronchiectasis is a heterogeneous disease with multiple aetiologies and diverse clinical
features. There is a general consensus that optimal treatment requires precision medicine …

Bronchiectasis is a highly complex entity that can be very challenging to investigate and
manage. Patients are diverse in their aetiology, symptoms, risk of complications and …

Bronchiectasis is a complex and heterogeneous disease. Its pathophysiology is poorly
understood, but chronic bronchial infection plays an important role in its natural history, and …

Bronchiectasis is a complex and heterogeneous disease with a myriad of pulmonary and
extrapulmonary etiologies. Bronchiectasis has a predominantly neutrophilic inflammatory …

Background Although a proven relationship exists between the blood eosinophil count
(BEC) and the severity of both asthma and COPD, its relationship with bronchiectasis has …

Whether high blood eosinophil counts may define a better phenotype in bronchiectasis
patients, as shown in chronic obstructive pulmonary disease (COPD), remains to be …